Naproxen

Product manufactured by Remedyrepack Inc.

Application Nr Approved Date Route Status External Links
ANDA075227 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Naproxen Delayed-Release Tablets Are Indicated For: The Relief Of The Signs And Symptoms Of: Rheumatoid Arthritis Osteoarthritis Ankylosing Spondylitis Polyarticular Juvenile Idiopathic Arthritis Naproxen Delayed-Release Tablets Are Non-Steroidal Anti-Inflammatory Drugs Indicated For: The Relief Of The Signs And Symptoms Of: Rheumatoid Arthritis Osteoarthritis Ankylosing Spondylitis Polyarticular Juvenile Idiopathic Arthritis

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Naproxen NAPROXEN ZINC105216

Comments